Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, designed to hinder the SARS-CoV-2 virus’s ability to replicate. Clinical ...
Influenza is an acute respiratory disease that causes epidemics and pandemics in the human population of temperate regions. Influenza epidemics occur every year during the winter months, affecting ...
November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Just one weekly puff from an asthma-like inhaler might one day protect you from the viral infections that make winters miserable - and could even save your life in the event of another pandemic. That ...
Recent advances in analytical chemistry have significantly improved the quantification of antiviral drugs in biological matrices. State‐of‐the‐art techniques combining high-performance liquid ...
Weill Cornell Medicine scientists created Cyclone, a simple tool that uses the antiviral drug acyclovir to safely switch ...
SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback